tradingkey.logo


Embecta Corp

EMBC
12.080USD
+0.160+1.34%
āļ›āļīāļ” 12/24, 13:00ETāļĢāļēāļ„āļēāļĨāđˆāļēāļŠāđ‰āļē 15 āļ™āļēāļ—āļĩ
706.63MāļĄāļđāļĨāļ„āđˆāļēāļ•āļĨāļēāļ”
7.38P/E TTM


āļĢāļēāļĒāļĨāļ°āđ€āļ­āļĩāļĒāļ”āđ€āļžāļīāđˆāļĄāđ€āļ•āļīāļĄāļ‚āļ­āļ‡ Embecta Corp āļšāļĢāļīāļĐāļąāļ—

Embecta Corp. is a global medical device company focused on providing solutions to improve the health and well-being of people living with diabetes. The Company has a portfolio of marketed products, including a variety of pen needles, syringes and safety injection devices. Its pen needles are sterile, single-use, medical devices, designed to be used in conjunction with pen injectors that inject insulin or other diabetes medications. It also sells safety pen needles, which have shields on both ends of the cannula that automatically deploy after the injection to help prevent needlestick exposure and injury during injection and disposal. Its traditional and safety pen needles are compatible and frequently used with pen injectors in the market. It sells sterile, single-use insulin syringes, which are used to inject insulin drawn from insulin vials. It also sells safety insulin syringes. It distributes its products through a variety of channels, including retail, hospitals and pharmacies.

āļ‚āđ‰āļ­āļĄāļđāļĨ Embecta Corp


āļŠāļąāļāļĨāļąāļāļĐāļ“āđŒāļĒāđˆāļ­āļ‚āļ­āļ‡āļŦāļļāđ‰āļ™EMBC
āļŠāļ·āđˆāļ­āļšāļĢāļīāļĐāļąāļ—Embecta Corp
āļ§āļąāļ™āļ—āļĩāđˆāđ€āļŠāļ™āļ­āļ‚āļēāļĒāļ„āļĢāļąāđ‰āļ‡āđāļĢāļMar 21, 2022
āļ‹āļĩāļ­āļĩāđ‚āļ­Kurdikar (Devdatt)
āļˆāļģāļ™āļ§āļ™āļžāļ™āļąāļāļ‡āļēāļ™1850
āļ›āļĢāļ°āđ€āļ āļ—āļāļēāļĢāļĢāļąāļāļĐāļēāļ„āļ§āļēāļĄāļ›āļĨāļ­āļ”āļ āļąāļĒOrdinary Share
āļŠāļīāđ‰āļ™āļ›āļĩāļ‡āļšāļ›āļĢāļ°āļĄāļēāļ“Mar 21
āļ—āļĩāđˆāļ­āļĒāļđāđˆ300 Kimball Drive
āđ€āļĄāļ·āļ­āļ‡PARSIPPANY
āļ•āļĨāļēāļ”āļŦāļĨāļąāļāļ—āļĢāļąāļžāļĒāđŒNASDAQ OMX - NASDAQ BASIC
āļ›āļĢāļ°āđ€āļ—āļĻUnited States of America
āļĢāļŦāļąāļŠāđ„āļ›āļĢāļĐāļ“āļĩāļĒāđŒ07054
āđ‚āļ—āļĢāļĻāļąāļžāļ—āđŒ18624010000
āđ€āļ§āđ‡āļšāđ„āļ‹āļ•āđŒhttps://www.embecta.com/
āļŠāļąāļāļĨāļąāļāļĐāļ“āđŒāļĒāđˆāļ­āļ‚āļ­āļ‡āļŦāļļāđ‰āļ™EMBC
āļ§āļąāļ™āļ—āļĩāđˆāđ€āļŠāļ™āļ­āļ‚āļēāļĒāļ„āļĢāļąāđ‰āļ‡āđāļĢāļMar 21, 2022
āļ‹āļĩāļ­āļĩāđ‚āļ­Kurdikar (Devdatt)

āļœāļđāđ‰āļšāļĢāļīāļŦāļēāļĢāļšāļĢāļīāļĐāļąāļ—āļ‚āļ­āļ‡ Embecta Corp


āļŠāļ·āđˆāļ­
āļŠāļ·āđˆāļ­/āļ•āļģāđāļŦāļ™āđˆāļ‡
āļ•āļģāđāļŦāļ™āđˆāļ‡
āļāļēāļĢāļ–āļ·āļ­āļŦāļļāđ‰āļ™
āđ€āļ›āļĨāļĩāđˆāļĒāļ™
Mr. Devdatt (Dev) Kurdikar
Mr. Devdatt (Dev) Kurdikar
Chairman of the Board, President, Chief Executive Officer
Chairman of the Board, President, Chief Executive Officer
285.01K
+1217.56%
Mr. Jacob (Jake) Elguicze
Mr. Jacob (Jake) Elguicze
Chief Financial Officer, Senior Vice President
Chief Financial Officer, Senior Vice President
116.67K
+636.80%
Mr. Jeffrey Z. (Jeff) Mann
Mr. Jeffrey Z. (Jeff) Mann
Senior Vice President, General Counsel, Product Development
Senior Vice President, General Counsel, Product Development
95.49K
+764.42%
Mr. Shaun Curtis
Mr. Shaun Curtis
Senior Vice President - Global Manufacturing, Supply Chain and Quality
Senior Vice President - Global Manufacturing, Supply Chain and Quality
40.28K
+513.31%
Ms. Jean Casner
Ms. Jean Casner
Chief Human Resources Officer, Senior Vice President
Chief Human Resources Officer, Senior Vice President
37.41K
+1816.50%
Mr. Christopher R. (Chris) Reidy
Mr. Christopher R. (Chris) Reidy
Director
Director
33.26K
+71.26%
Mr. Robert J. (Bob) Hombach, CPA
Mr. Robert J. (Bob) Hombach, CPA
Independent Director
Independent Director
27.73K
+99.66%
Ms. Carrie L. Anderson
Ms. Carrie L. Anderson
Independent Director
Independent Director
27.72K
+99.70%
Dr. Milton Mayo Morris, Ph.D.
Dr. Milton Mayo Morris, Ph.D.
Independent Director
Independent Director
24.21K
+79.71%
Mr. Pravesh Khandelwal
Mr. Pravesh Khandelwal
Investor Relations
Investor Relations
--
--
āļ”āļđāđ€āļžāļīāđˆāļĄāđ€āļ•āļīāļĄ
āļŠāļ·āđˆāļ­
āļŠāļ·āđˆāļ­/āļ•āļģāđāļŦāļ™āđˆāļ‡
āļ•āļģāđāļŦāļ™āđˆāļ‡
āļāļēāļĢāļ–āļ·āļ­āļŦāļļāđ‰āļ™
āđ€āļ›āļĨāļĩāđˆāļĒāļ™
Mr. Devdatt (Dev) Kurdikar
Mr. Devdatt (Dev) Kurdikar
Chairman of the Board, President, Chief Executive Officer
Chairman of the Board, President, Chief Executive Officer
285.01K
+1217.56%
Mr. Jacob (Jake) Elguicze
Mr. Jacob (Jake) Elguicze
Chief Financial Officer, Senior Vice President
Chief Financial Officer, Senior Vice President
116.67K
+636.80%
Mr. Jeffrey Z. (Jeff) Mann
Mr. Jeffrey Z. (Jeff) Mann
Senior Vice President, General Counsel, Product Development
Senior Vice President, General Counsel, Product Development
95.49K
+764.42%
Mr. Shaun Curtis
Mr. Shaun Curtis
Senior Vice President - Global Manufacturing, Supply Chain and Quality
Senior Vice President - Global Manufacturing, Supply Chain and Quality
40.28K
+513.31%
Ms. Jean Casner
Ms. Jean Casner
Chief Human Resources Officer, Senior Vice President
Chief Human Resources Officer, Senior Vice President
37.41K
+1816.50%
Mr. Christopher R. (Chris) Reidy
Mr. Christopher R. (Chris) Reidy
Director
Director
33.26K
+71.26%

āļŠāļąāļ”āļŠāđˆāļ§āļ™āļ‚āļ­āļ‡āļĢāļēāļĒāđ„āļ”āđ‰

āļŠāļāļļāļĨāđ€āļ‡āļīāļ™: USDāļ­āļąāļ›āđ€āļ”āļ•āđ€āļĄāļ·āđˆāļ­: āļ§āļąāļ™āļˆāļąāļ™āļ—āļĢāđŒāļ—āļĩāđˆ 6 āļ•.āļ„.
āļŠāļāļļāļĨāđ€āļ‡āļīāļ™: USDāļ­āļąāļ›āđ€āļ”āļ•āđ€āļĄāļ·āđˆāļ­: āļ§āļąāļ™āļˆāļąāļ™āļ—āļĢāđŒāļ—āļĩāđˆ 6 āļ•.āļ„.
FY2025Q3
FY2025Q2
FY2025Q1
FY2024
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022
FY2022Q4
FY2022Q3
FY2021
FY2020
FY2019
āļ•āļēāļĄāļ˜āļļāļĢāļāļīāļˆUSD
āļŠāļ·āđˆāļ­
āļĢāļēāļĒāđ„āļ”āđ‰
āļŠāļąāļ”āļŠāđˆāļ§āļ™
Pen Needles
216.90M
73.40%
Syringes
35.10M
11.88%
Safety
34.80M
11.78%
Manufacturing Facility
5.50M
1.86%
Other
3.20M
1.08%
āļ•āļēāļĄāļ āļđāļĄāļīāļ āļēāļ„USD
āļŠāļ·āđˆāļ­
āļĢāļēāļĒāđ„āļ”āđ‰
āļŠāļąāļ”āļŠāđˆāļ§āļ™
United States
160.20M
54.21%
International
135.30M
45.79%
āļ•āļēāļĄāļ˜āļļāļĢāļāļīāļˆ
āļ•āļēāļĄāļ āļđāļĄāļīāļ āļēāļ„
āļ•āļēāļĄāļ˜āļļāļĢāļāļīāļˆUSD
āļŠāļ·āđˆāļ­
āļĢāļēāļĒāđ„āļ”āđ‰
āļŠāļąāļ”āļŠāđˆāļ§āļ™
Pen Needles
216.90M
73.40%
Syringes
35.10M
11.88%
Safety
34.80M
11.78%
Manufacturing Facility
5.50M
1.86%
Other
3.20M
1.08%

āļŠāļ–āļīāļ•āļīāļāļēāļĢāļ–āļ·āļ­āļŦāļļāđ‰āļ™

āļ­āļąāļ›āđ€āļ”āļ•āđ€āļĄāļ·āđˆāļ­: āļ§āļąāļ™āļ­āļēāļ—āļīāļ•āļĒāđŒāļ—āļĩāđˆ 16 āļž.āļĒ.
āļ­āļąāļ›āđ€āļ”āļ•āđ€āļĄāļ·āđˆāļ­: āļ§āļąāļ™āļ­āļēāļ—āļīāļ•āļĒāđŒāļ—āļĩāđˆ 16 āļž.āļĒ.
āļœāļđāđ‰āļ–āļ·āļ­āļŦāļļāđ‰āļ™
āļ›āļĢāļ°āđ€āļ āļ—āļœāļđāđ‰āļ–āļ·āļ­āļŦāļļāđ‰āļ™
āļœāļđāđ‰āļ–āļ·āļ­āļŦāļļāđ‰āļ™
āļœāļđāđ‰āļ–āļ·āļ­āļŦāļļāđ‰āļ™
āļŠāļąāļ”āļŠāđˆāļ§āļ™
BlackRock Institutional Trust Company, N.A.
13.32%
The Vanguard Group, Inc.
9.08%
American Century Investment Management, Inc.
8.76%
River Road Asset Management, LLC
5.48%
Deerfield Management Company, L.P.
4.43%
āļ­āļ·āđˆāļ™ āđ†
58.93%
āļœāļđāđ‰āļ–āļ·āļ­āļŦāļļāđ‰āļ™
āļœāļđāđ‰āļ–āļ·āļ­āļŦāļļāđ‰āļ™
āļŠāļąāļ”āļŠāđˆāļ§āļ™
BlackRock Institutional Trust Company, N.A.
13.32%
The Vanguard Group, Inc.
9.08%
American Century Investment Management, Inc.
8.76%
River Road Asset Management, LLC
5.48%
Deerfield Management Company, L.P.
4.43%
āļ­āļ·āđˆāļ™ āđ†
58.93%
āļ›āļĢāļ°āđ€āļ āļ—āļœāļđāđ‰āļ–āļ·āļ­āļŦāļļāđ‰āļ™
āļœāļđāđ‰āļ–āļ·āļ­āļŦāļļāđ‰āļ™
āļŠāļąāļ”āļŠāđˆāļ§āļ™
Investment Advisor
48.94%
Investment Advisor/Hedge Fund
31.49%
Hedge Fund
10.58%
Research Firm
5.48%
Pension Fund
2.25%
Individual Investor
1.46%
Bank and Trust
0.54%
Family Office
0.40%
Sovereign Wealth Fund
0.19%

āļāļēāļĢāļ–āļ·āļ­āļŦāļļāđ‰āļ™āļ‚āļ­āļ‡āļŠāļ–āļēāļšāļąāļ™


āļ­āļąāļ›āđ€āļ”āļ•āđ€āļĄāļ·āđˆāļ­: āļ§āļąāļ™āļˆāļąāļ™āļ—āļĢāđŒāļ—āļĩāđˆ 8 āļ˜.āļ„.
āļ­āļąāļ›āđ€āļ”āļ•āđ€āļĄāļ·āđˆāļ­: āļ§āļąāļ™āļˆāļąāļ™āļ—āļĢāđŒāļ—āļĩāđˆ 8 āļ˜.āļ„.
āļŠāđˆāļ§āļ‡āđ€āļ§āļĨāļēāļāļēāļĢāļĢāļēāļĒāļ‡āļēāļ™
āļˆāļģāļ™āļ§āļ™āļŠāļ–āļēāļšāļąāļ™
āļŦāļļāđ‰āļ™āļ—āļĩāđˆāļ–āļ·āļ­āļ„āļĢāļ­āļ‡
āļŠāļąāļ”āļŠāđˆāļ§āļ™
āđ€āļ›āļĨāļĩāđˆāļĒāļ™
2025Q4
771
58.75M
107.09%
-8.51K
2025Q3
810
58.76M
110.40%
-1.03M
2025Q2
820
59.48M
109.25%
+307.16K
2025Q1
855
59.15M
106.14%
-2.75M
2024Q4
884
57.08M
105.66%
+385.73K
2024Q3
903
56.12M
114.14%
-1.32M
2024Q2
966
57.37M
112.89%
+262.03K
2024Q1
996
57.10M
113.18%
-8.07M
2023Q4
1007
56.71M
107.91%
+769.57K
2023Q3
972
57.63M
107.02%
+1.71M
āļ”āļđāđ€āļžāļīāđˆāļĄāđ€āļ•āļīāļĄ

āļāļīāļˆāļāļĢāļĢāļĄāļœāļđāđ‰āļ–āļ·āļ­āļŦāļļāđ‰āļ™


āļŠāļ·āđˆāļ­
āļŦāļļāđ‰āļ™āļ—āļĩāđˆāļ–āļ·āļ­āļ„āļĢāļ­āļ‡
āļŠāļąāļ”āļŠāđˆāļ§āļ™
āđ€āļ›āļĨāļĩāđˆāļĒāļ™
āđ€āļ›āļĨāļĩāđˆāļĒāļ™%
āļ§āļąāļ™āļ—āļĩāđˆ
BlackRock Institutional Trust Company, N.A.
8.03M
13.73%
-278.98K
-3.36%
Jun 30, 2025
The Vanguard Group, Inc.
5.40M
9.24%
-1.27M
-19.01%
Jun 30, 2025
American Century Investment Management, Inc.
5.20M
8.88%
+1.38M
+36.25%
Jun 30, 2025
River Road Asset Management, LLC
3.24M
5.54%
+12.35K
+0.38%
Jun 30, 2025
Deerfield Management Company, L.P.
2.75M
4.7%
+29.18K
+1.07%
Jun 30, 2025
State Street Investment Management (US)
2.40M
4.1%
+15.14K
+0.64%
Jun 30, 2025
Yacktman Asset Management LP
2.37M
4.06%
+16.07K
+0.68%
Jun 30, 2025
Jefferies LLC
1.34M
2.3%
+769.71K
+134.33%
Jun 30, 2025
William Blair Investment Management, LLC
1.99M
3.41%
+14.23K
+0.72%
Jun 30, 2025
Millennium Management LLC
1.82M
3.12%
+937.99K
+105.75%
Jun 30, 2025
āļ”āļđāđ€āļžāļīāđˆāļĄāđ€āļ•āļīāļĄ

ETF āļ—āļĩāđˆāđ€āļāļĩāđˆāļĒāļ§āļ‚āđ‰āļ­āļ‡


āļ­āļąāļ›āđ€āļ”āļ•āđ€āļĄāļ·āđˆāļ­: āļ§āļąāļ™āđ€āļŠāļēāļĢāđŒāļ—āļĩāđˆ 6 āļ˜.āļ„.
āļ­āļąāļ›āđ€āļ”āļ•āđ€āļĄāļ·āđˆāļ­: āļ§āļąāļ™āđ€āļŠāļēāļĢāđŒāļ—āļĩāđˆ 6 āļ˜.āļ„.
āļŠāļ·āđˆāļ­
āļŠāļąāļ”āļŠāđˆāļ§āļ™
ETC 6 Meridian Small Cap Equity ETF
1.09%
State Street SPDR S&P Health Care Equipment ETF
0.85%
Lattice Hartford Multifactor Small Cap ETF
0.71%
Pacer US Small Cap Cash Cows Growth Leaders ETF
0.65%
Invesco S&P Spin-Off ETF
0.63%
Invesco NASDAQ Future Gen 200 ETF
0.49%
Invesco S&P SmallCap Health Care ETF
0.48%
Global X Aging Population ETF
0.31%
Royce Quant Small-Cap Quality Value ETF
0.29%
Inspire Small/Mid Cap ESG ETF
0.19%
āļ”āļđāđ€āļžāļīāđˆāļĄāđ€āļ•āļīāļĄ
ETC 6 Meridian Small Cap Equity ETF
āļŠāļąāļ”āļŠāđˆāļ§āļ™1.09%
State Street SPDR S&P Health Care Equipment ETF
āļŠāļąāļ”āļŠāđˆāļ§āļ™0.85%
Lattice Hartford Multifactor Small Cap ETF
āļŠāļąāļ”āļŠāđˆāļ§āļ™0.71%
Pacer US Small Cap Cash Cows Growth Leaders ETF
āļŠāļąāļ”āļŠāđˆāļ§āļ™0.65%
Invesco S&P Spin-Off ETF
āļŠāļąāļ”āļŠāđˆāļ§āļ™0.63%
Invesco NASDAQ Future Gen 200 ETF
āļŠāļąāļ”āļŠāđˆāļ§āļ™0.49%
Invesco S&P SmallCap Health Care ETF
āļŠāļąāļ”āļŠāđˆāļ§āļ™0.48%
Global X Aging Population ETF
āļŠāļąāļ”āļŠāđˆāļ§āļ™0.31%
Royce Quant Small-Cap Quality Value ETF
āļŠāļąāļ”āļŠāđˆāļ§āļ™0.29%
Inspire Small/Mid Cap ESG ETF
āļŠāļąāļ”āļŠāđˆāļ§āļ™0.19%

āđ€āļ‡āļīāļ™āļ›āļąāļ™āļœāļĨ


āļĄāļĩāļāļēāļĢāļˆāđˆāļēāļĒāđ€āļ‡āļīāļ™āļ›āļąāļ™āļœāļĨāđ€āļ›āđ‡āļ™āļˆāļģāļ™āļ§āļ™āļĢāļ§āļĄ 112.50M USD āđƒāļ™āļŠāđˆāļ§āļ‡ 5 āļ›āļĩāļ—āļĩāđˆāļœāđˆāļēāļ™āļĄāļē
āļ§āļąāļ™āļ—āļĩāđˆ
āđ€āļ‡āļīāļ™āļ›āļąāļ™āļœāļĨ
āļ§āļąāļ™āļ—āļĩāđˆāļšāļąāļ™āļ—āļķāļ
āļ§āļąāļ™āļ—āļĩāđˆāļŠāļģāļĢāļ°āđ€āļ‡āļīāļ™
āļ§āļąāļ™āļ—āļĩāđˆāđ„āļĄāđˆāđ„āļ”āđ‰āļĢāļąāļšāļŠāļīāļ—āļ˜āļīāļ›āļąāļ™āļœāļĨ
Aug 08, 2025
EMBC.NB Interim Cash Dividend of gross USD 0.15 paid on Sep 15, 2025 going ex on Aug 29, 2025
Aug 29, 2025
Sep 15, 2025
Aug 29, 2025
May 09, 2025
EMBC.NB Interim Cash Dividend of gross USD 0.15 paid on Jun 13, 2025 going ex on May 28, 2025
May 28, 2025
Jun 13, 2025
May 28, 2025
Feb 06, 2025
EMBC.NB Interim Cash Dividend of gross USD 0.15 paid on Mar 14, 2025 going ex on Feb 28, 2025
Feb 28, 2025
Mar 14, 2025
Feb 28, 2025
Nov 26, 2024
EMBC.NB Final Cash Dividend of gross USD 0.15 paid on Dec 18, 2024 going ex on Dec 06, 2024
Dec 06, 2024
Dec 18, 2024
Dec 06, 2024
Aug 09, 2024
EMBC.NB Interim Cash Dividend of gross USD 0.15 paid on Sep 13, 2024 going ex on Aug 27, 2024
Aug 27, 2024
Sep 13, 2024
Aug 27, 2024
May 09, 2024
EMBC.NB Interim Cash Dividend of gross USD 0.15 paid on Jun 14, 2024 going ex on May 24, 2024
May 28, 2024
Jun 14, 2024
May 24, 2024
Feb 09, 2024
EMBC.NB Interim Cash Dividend of gross USD 0.15 paid on Mar 15, 2024 going ex on Feb 27, 2024
Feb 28, 2024
Mar 15, 2024
Feb 27, 2024
Nov 21, 2023
EMBC.NB Final Cash Dividend of gross USD 0.15 paid on Dec 15, 2023 going ex on Dec 01, 2023
Dec 04, 2023
Dec 15, 2023
Dec 01, 2023
Aug 08, 2023
EMBC.NB Interim Cash Dividend of gross USD 0.15 paid on Sep 13, 2023 going ex on Aug 24, 2023
Aug 25, 2023
Sep 13, 2023
Aug 24, 2023
May 12, 2023
EMBC.NB Interim Cash Dividend of gross USD 0.15 paid on Jun 13, 2023 going ex on May 25, 2023
May 29, 2023
Jun 13, 2023
May 25, 2023
āļ”āļđāđ€āļžāļīāđˆāļĄāđ€āļ•āļīāļĄ

āļāļēāļĢāđāļšāđˆāļ‡āļŦāļļāđ‰āļ™


āļ§āļąāļ™āļ—āļĩāđˆ
āļ›āļĢāļ°āđ€āļ āļ—
āļ­āļąāļ•āļĢāļēāļŠāđˆāļ§āļ™
āđ„āļĄāđˆāļĄāļĩāļ‚āđ‰āļ­āļĄāļđāļĨ
āļ§āļąāļ™āļ—āļĩāđˆ
āļ›āļĢāļ°āđ€āļ āļ—
āļ­āļąāļ•āļĢāļēāļŠāđˆāļ§āļ™
āđ„āļĄāđˆāļĄāļĩāļ‚āđ‰āļ­āļĄāļđāļĨ

āļ„āļģāļ–āļēāļĄāļ—āļĩāđˆāļžāļšāļšāđˆāļ­āļĒ

āđƒāļ„āļĢāļ„āļ·āļ­āļœāļđāđ‰āļ–āļ·āļ­āļŦāļļāđ‰āļ™āļŦāđ‰āļēāļ­āļąāļ™āļ”āļąāļšāđāļĢāļāļ‚āļ­āļ‡ Embecta Corp?


āļœāļđāđ‰āļ–āļ·āļ­āļŦāļļāđ‰āļ™āļŦāđ‰āļēāļ­āļąāļ™āļ”āļąāļšāđāļĢāļāļ‚āļ­āļ‡ Embecta Corp āđ„āļ”āđ‰āđāļāđˆ:
BlackRock Institutional Trust Company, N.A. āļ–āļ·āļ­āļ„āļĢāļ­āļ‡āļŦāļļāđ‰āļ™āļˆāļģāļ™āļ§āļ™ 8.03M āļŦāļļāđ‰āļ™ āļ„āļīāļ”āđ€āļ›āđ‡āļ™ 13.73% āļ‚āļ­āļ‡āļŦāļļāđ‰āļ™āļ—āļąāđ‰āļ‡āļŦāļĄāļ”
The Vanguard Group, Inc. āļ–āļ·āļ­āļ„āļĢāļ­āļ‡āļŦāļļāđ‰āļ™āļˆāļģāļ™āļ§āļ™ 5.40M āļŦāļļāđ‰āļ™ āļ„āļīāļ”āđ€āļ›āđ‡āļ™ 9.24% āļ‚āļ­āļ‡āļŦāļļāđ‰āļ™āļ—āļąāđ‰āļ‡āļŦāļĄāļ”
American Century Investment Management, Inc. āļ–āļ·āļ­āļ„āļĢāļ­āļ‡āļŦāļļāđ‰āļ™āļˆāļģāļ™āļ§āļ™ 5.20M āļŦāļļāđ‰āļ™ āļ„āļīāļ”āđ€āļ›āđ‡āļ™ 8.88% āļ‚āļ­āļ‡āļŦāļļāđ‰āļ™āļ—āļąāđ‰āļ‡āļŦāļĄāļ”
River Road Asset Management, LLC āļ–āļ·āļ­āļ„āļĢāļ­āļ‡āļŦāļļāđ‰āļ™āļˆāļģāļ™āļ§āļ™ 3.24M āļŦāļļāđ‰āļ™ āļ„āļīāļ”āđ€āļ›āđ‡āļ™ 5.54% āļ‚āļ­āļ‡āļŦāļļāđ‰āļ™āļ—āļąāđ‰āļ‡āļŦāļĄāļ”
Deerfield Management Company, L.P. āļ–āļ·āļ­āļ„āļĢāļ­āļ‡āļŦāļļāđ‰āļ™āļˆāļģāļ™āļ§āļ™ 2.75M āļŦāļļāđ‰āļ™ āļ„āļīāļ”āđ€āļ›āđ‡āļ™ 4.70% āļ‚āļ­āļ‡āļŦāļļāđ‰āļ™āļ—āļąāđ‰āļ‡āļŦāļĄāļ”

āļ›āļĢāļ°āđ€āļ āļ—āļœāļđāđ‰āļ–āļ·āļ­āļŦāļļāđ‰āļ™āļŠāļēāļĄāļ­āļąāļ™āļ”āļąāļšāđāļĢāļāļ‚āļ­āļ‡ Embecta Corp āļ„āļ·āļ­āļ­āļ°āđ„āļĢ?


āļ›āļĢāļ°āđ€āļ āļ—āļœāļđāđ‰āļ–āļ·āļ­āļŦāļļāđ‰āļ™āļŠāļēāļĄāļ­āļąāļ™āļ”āļąāļšāđāļĢāļāļ‚āļ­āļ‡ Embecta Corp āđ„āļ”āđ‰āđāļāđˆ
BlackRock Institutional Trust Company, N.A.
The Vanguard Group, Inc.
American Century Investment Management, Inc.

āļĄāļĩāļāļĩāđˆāļŠāļ–āļēāļšāļąāļ™āļ—āļĩāđˆāļ–āļ·āļ­āļŦāļļāđ‰āļ™āļ‚āļ­āļ‡ Embecta Corp (EMBC)?


āļ“ āļ§āļąāļ™āļ—āļĩāđˆ 2025Q4 āļĄāļĩāļŠāļ–āļēāļšāļąāļ™āļˆāļģāļ™āļ§āļ™ 771 āđāļŦāđˆāļ‡āļ—āļĩāđˆāļ–āļ·āļ­āļŦāļļāđ‰āļ™āļ‚āļ­āļ‡ Embecta Corp āđ‚āļ”āļĒāļĄāļĩāļĄāļđāļĨāļ„āđˆāļēāļĢāļ§āļĄāļ›āļĢāļ°āļĄāļēāļ“ 58.75M āļ„āļīāļ”āđ€āļ›āđ‡āļ™ 107.09% āļ‚āļ­āļ‡āļŦāļļāđ‰āļ™āļ—āļąāđ‰āļ‡āļŦāļĄāļ” āđ€āļĄāļ·āđˆāļ­āđ€āļ—āļĩāļĒāļšāļāļąāļšāļ§āļąāļ™āļ—āļĩāđˆ 2025Q3 āļāļēāļĢāļ–āļ·āļ­āļŦāļļāđ‰āļ™āļ‚āļ­āļ‡āļŠāļ–āļēāļšāļąāļ™āđ„āļ”āđ‰āđ€āļžāļīāđˆāļĄāļ‚āļķāđ‰āļ™ -3.30%

āđāļŦāļĨāđˆāļ‡āļĢāļēāļĒāđ„āļ”āđ‰āļŦāļĨāļąāļāļ‚āļ­āļ‡ Embecta Corp āļ„āļ·āļ­āļ­āļ°āđ„āļĢ?


āđ€āļĄāļ·āđˆāļ­āļ§āļąāļ™āļ—āļĩāđˆ FY2025Q3 āļ˜āļļāļĢāļāļīāļˆāļ”āđ‰āļēāļ™ Pen Needles āļŠāļĢāđ‰āļēāļ‡āļĢāļēāļĒāđ„āļ”āđ‰āļŠāļđāļ‡āļŠāļļāļ”āđƒāļŦāđ‰āļāļąāļš Embecta Corp āļ„āļīāļ”āđ€āļ›āđ‡āļ™āļĄāļđāļĨāļ„āđˆāļē 216.90M āđāļĨāļ°āļ„āļīāļ”āđ€āļ›āđ‡āļ™ 73.40% āļ‚āļ­āļ‡āļĢāļēāļĒāđ„āļ”āđ‰āļĢāļ§āļĄ
KeyAI
î™